The single most over-ordered, over-interpreted, and over-treated blood test in Indian outpatient practice in 2026 is the vitamin D test. Indian commercial labs uniformly print “deficient” or “insufficient” in red when a result is under 30 ng/mL, which means 70-80% of every adult who walks in the door gets labelled deficient — including people whose physiology, calcium, and PTH are entirely normal. The result is an over-medicalisation cycle worth an estimated thousands of crores a year: test (₹500-₹1,800), supplement (₹35-₹90 per sachet), re-test (₹500-₹1,800), retreat, and repeat.
The 2024 Endocrine Society Clinical Practice Guideline quietly demolished the basis of this cycle. It recommends AGAINST routine screening of healthy adults, declines to set a numeric sufficiency threshold, and reserves empiric supplementation for just four groups: children 1-18, pregnant individuals, adults ≥75, and people with prediabetes. Indian lab practice has not caught up. This guide will give you the actual 2026 normal-range numbers, the exact city-wise cost of the vitamin D test in India, the Calcirol 60K protocol when treatment is genuinely indicated, the toxicity risk that is rising in Indian case reports, and the answer to the question Indian clinicians rarely ask honestly — do I even need this test?
Internal links go to our companion lab-test guides on the CBC test normal range for Indians, the HbA1c test guide for diabetes screening, and the annual diabetes testing schedule cost plan — because vitamin D almost never travels alone on an Indian lab requisition.
Quick Answer: The vitamin D test measures serum 25-hydroxyvitamin D (25(OH)D) in ng/mL. Most Indian labs use <20 ng/mL = deficient, 20-30 ng/mL = insufficient, ≥30 ng/mL = sufficient. The IOM/NIH consider ≥20 ng/mL adequate for 97.5% of the population. Cost in India ranges from ₹499 at Redcliffe Labs to ₹1,800 at Metropolis/SRL. No fasting needed. Order 25(OH)D, not 1,25(OH)2D. Per the 2024 Endocrine Society guideline, healthy adults do not need routine screening.
What does the vitamin D test actually measure?
The standard “vitamin D test” measures serum 25-hydroxyvitamin D (25(OH)D), also written as 25-OH-D, calcidiol, or “Vitamin D Total”. It captures both D2 (ergocalciferol, plant source) and D3 (cholecalciferol, animal/sun source) metabolites and reflects your combined intake from diet, supplements, and sun over the previous 2-3 weeks. It is the international gold standard for vitamin D status because of its 15-day half-life and tight correlation with body stores.
| Test name | What it measures | Half-life | When to order |
|---|---|---|---|
| 25-Hydroxyvitamin D (25(OH)D) | Storage form — best status marker | ~15 days | Always — this is the routine test |
| 1,25-Dihydroxyvitamin D (calcitriol) | Active hormone | ~4 hours | Sarcoidosis, granulomatous TB, CKD, vitamin D-dependent rickets |
| Vitamin D2 only | Ergocalciferol (plant) | Days | Almost never useful alone |
| Vitamin D3 only | Cholecalciferol (animal/sun) | Days | Almost never useful alone |
Take this home: if your lab requisition says anything other than “25-hydroxyvitamin D” or “Vitamin D Total” (which includes 25(OH)D2 + 25(OH)D3), the wrong test has been ordered. 1,25-Dihydroxyvitamin D is falsely normal or even high in deficiency because PTH-driven feedback upregulates 1-alpha-hydroxylase — you can have severe 25(OH)D deficiency with a perfectly normal calcitriol level. Ordering it routinely costs the patient ₹2,800-₹3,500 for the wrong answer.
Units, fasting, sample requirements
- Units in India: ng/mL (a few tertiary labs report nmol/L; conversion factor is 2.5x, so 30 ng/mL = 75 nmol/L)
- Fasting: Not required. Skip your morning vitamin D supplement to avoid spuriously high readings.
- Sample: 3-5 mL serum in a plain (red-top) or SST tube
- Method: CLIA chemiluminescent immunoassay (Roche/Abbott/Siemens) at most chains; LC-MS/MS at SRL Centre of Excellence, Metropolis premium, and AIIMS
- Turnaround: 12-24 hours at major private chains; 3-7 days at government hospitals
What is the normal range for vitamin D in 2026 — and why the printed cutoff on your report is probably wrong?
The numeric thresholds on your Indian lab report are based on the 2011 Endocrine Society guideline (the “Holick threshold”) and were imported wholesale from mostly-Caucasian data. Three different bodies disagree on what counts as sufficient, and the 2024 update from the Endocrine Society itself walked back the original threshold.
| Status band | Indian lab cutoff (most chains) | IOM / NIH (2011) | IAP 2021 (paediatrics) | Endocrine Society 2024 |
|---|---|---|---|---|
| Deficient | <20 ng/mL | <12 ng/mL | <12 ng/mL | No numeric threshold endorsed |
| Insufficient | 20-30 ng/mL | 12-20 ng/mL | 12-20 ng/mL | No numeric threshold endorsed |
| Sufficient | ≥30 ng/mL | ≥20 ng/mL | ≥20 ng/mL | ”Adequate” not numerically defined |
| Optimal (some clinicians) | 40-60 ng/mL | Not endorsed | Not endorsed | Not endorsed |
| Toxic | >100 ng/mL | >100 ng/mL | >100 ng/mL | >100 ng/mL |
The 2024 Endocrine Society Clinical Practice Guideline on vitamin D for the prevention of disease is the most important update in this space in a decade. It made four substantive changes from the 2011 Holick framework:
- Recommends against routine 25(OH)D screening in healthy adults — including those with dark skin or obesity.
- Declines to endorse a numeric sufficiency threshold because the evidence does not support one.
- Targets empiric supplementation at four groups only: children 1-18, pregnant individuals, adults ≥75, and people with prediabetes.
- Advises healthy adults under 75 to take only the RDA (600 IU/day) — not higher doses.
The implication for India is uncomfortable: under 2024 criteria, the vast majority of Indians currently being tested and supplemented have no clinical indication for either. Indian-specific work from the IJEM 2025 Expert Group Consensus on Prevention and Treatment of Vitamin D Deficiency in India and PMC 10746810 suggests that the physiological threshold above which Indian normocalcaemia and PTH suppression are maintained is closer to 12-13.5 ng/mL, not 30 ng/mL — meaning the 30 ng/mL cutoff overestimates deficiency in Indian skin.
What most people get wrong here: seeing “Insufficient” or “Deficient” highlighted in red on your lab report is not a diagnosis. A 25-year-old healthy office worker with a 24 ng/mL reading, normal calcium, and no symptoms does not need 8 weeks of 60,000 IU. Treat the patient, not the number.
How much does the vitamin D test cost across Indian labs in 2026?
Standalone vitamin D testing in India spans ₹499 to ₹1,800 across the seven major diagnostic chains. The variance is driven by methodology (CLIA vs LC-MS/MS), city tier, and how aggressively the lab is positioning the test in promo bundles.
| Lab chain | Standalone price (₹) | Method | Notes |
|---|---|---|---|
| Redcliffe Labs | 499 | CLIA | Delhi promotional, free home collection |
| Thyrocare | 600-900 | CLIA | Cheapest among major chains; Aarogyam packages bundle with B12 |
| Tata 1mg Labs | 600-1,200 | CLIA | Bangalore/Hyderabad cheaper than tier-2 |
| Apollo Diagnostics | 900-1,500 | CLIA | Pan-India network |
| Dr Lal PathLabs | 800-1,550 | CLIA | Delhi ₹1,550, tier-2 ₹800-₹1,000 |
| SRL Diagnostics | 1,300-1,800 | CLIA / LC-MS/MS | LC-MS/MS variant ₹1,800-₹2,500 |
| Metropolis Centre of Excellence | 1,400-1,800 | LC-MS/MS available | Premium positioning |
| Government (AIIMS, PGI, state) | 0-150 | CLIA | 3-7 day wait |
Take this home: if you have a genuine indication for testing and no insurance, Redcliffe (₹499) or Thyrocare (₹600-₹900) are the cheapest accurate options. If your bone-health workup is being run by an endocrinologist who wants LC-MS/MS precision (post-bariatric, sarcoidosis suspicion, suspected granulomatous disease), pay the premium and use SRL Centre of Excellence or Metropolis.
Why the price spread is so wide
Vitamin D is a high-volume, low-marginal-cost commodity test. Chains use it as a loss-leader in master health checkups (the marginal cost of adding vitamin D into a ₹1,999 full-body panel is ₹150-₹300), and as a promotional anchor in metro markets (Redcliffe’s ₹499 standalone Delhi price is an acquisition tool). At the premium end, LC-MS/MS pricing reflects the higher reagent and instrumentation cost — but for routine screening it is overkill.
A full annual lab panel with vitamin D inside it is often cheaper than running them individually — the same logic that drives our annual diabetes testing schedule cost plan for India.
Why is 70-90% of India vitamin D deficient despite year-round sun?
India sits between 8°N (Kanyakumari) and 35°N (Kashmir) — well inside the UV-B-rich tropical and subtropical band. Endogenous skin synthesis should be the dominant source for most of the population year-round. Yet pooled Indian studies report 70-90% deficiency at the <30 ng/mL cutoff and 50-80% at <20 ng/mL. Seven independent factors stack against synthesis.
| Factor | Effect on vitamin D synthesis | India-specific magnitude |
|---|---|---|
| Skin pigmentation (Fitzpatrick V-VI) | Melanin absorbs UV-B | 3-6× the sun exposure needed vs Caucasian skin |
| Indoor urban lifestyle | No UV-B exposure | Bhopal urban 91.6% deficient vs rural 66.5% |
| Full-body clothing | Blocks UV-B on covered surface | Sari/salwar/abaya cover 70-90% of body |
| Sunscreen + skin-lightening | Blocks UV-B intentionally | SPF 15 blocks 93% UV-B; SPF 50 blocks 98% |
| Air pollution (PM2.5) | Filters UV-B at ground level | 30-60% UV-B reduction in Delhi/Patna/Lucknow |
| Vegetarian / Jain diet | No animal D3 sources | 30-40% of Indian households |
| Patchy FSSAI fortification | Most loose milk/oil unfortified | ”+F” logo voluntary, not mandatory |
The single biggest counter-intuitive insight from the Nutrients 2014 review on vitamin D deficiency in India is the urban-rural reversal: Indian city-dwellers are more deficient than villagers, not less. The desk-bound IT worker in Bengaluru gets less effective sun than the agricultural worker in a Tamil Nadu village despite living at the same latitude. Air-conditioning, glass-fronted high-rises, indoor commutes, full-coverage office wear, and skin-lightening cosmetic routines do more damage than latitude does good.
What most people get wrong here: morning sun is NOT the best time for vitamin D. UV-B is only available when the sun is high enough — typically a solar zenith above 50°, which translates to 11 am to 2 pm. The traditional Indian advice to “sit in the morning sun for vitamin D” is biologically wrong; it gives you UV-A (which damages skin) without meaningful UV-B (which makes vitamin D).
How much sun is actually enough?
For Indian Fitzpatrick IV-VI skin in tier-1 cities with average pollution:
- 15-30 minutes of direct midday sun (11 am-2 pm) on uncovered face, arms, hands, and lower legs (about 25% of body surface)
- 3-4 days per week
- Without sunscreen on those specific exposed areas during that window
- More (30-60 minutes) on high-AQI or overcast days
For office workers who cannot achieve this — which is most readers — dietary intake + supplementation become the realistic route. Pure-vegetarian and Jain readers should especially read on, because dietary D3 is overwhelmingly animal-sourced.
What dietary sources of vitamin D actually exist in India?
Vitamin D is the rare nutrient that cannot be obtained in meaningful quantities from a typical Indian vegetarian diet. Plants supply essentially zero D3. The few options that exist are limited, and FSSAI fortification of milk and oil — while a real public-health win — is voluntary and patchy in adoption.
| Food | Vitamin D content (IU) | Comments |
|---|---|---|
| Salmon (wild) | 600-1,000 per 100 g | Densest natural source; rarely on Indian plates |
| Mackerel / hilsa | 360 per 100 g | Coastal availability |
| Sardines (canned) | 270 per 100 g | Affordable in coastal cities |
| Tuna | 150 per 100 g | Canned widely available |
| Cod liver oil | 450 per teaspoon | Available in pharmacies |
| Egg yolk | 40 per yolk | Lacto-ovo vegetarians |
| Fortified milk (+F logo) | 50-100 per glass | Mother Dairy, Amul Gold +F, Nestlé a+, Britannia |
| Fortified edible oil (+F logo) | 10 per gram | Saffola, Fortune, Sundrop, Dhara fortified |
| UV-exposed mushrooms | 100-400 per 100 g | Sun-dried oyster, button, shiitake — D2 |
| Chicken / mutton | Negligible | Not a meaningful source |
| Liver (chicken/mutton) | 40-100 per 100 g | Modest contribution |
The Food Safety and Standards Authority of India (FSSAI) fortification regulations, finalised 2017-2018, permit voluntary +F fortification of edible oil and milk with vitamins A and D. The intent was excellent. Adoption is the problem: branded packaged milk (Mother Dairy, Amul Gold +F, Nestlé a+) and major oil brands (Saffola, Fortune, Sundrop, Dhara fortified variants) largely comply, but loose milk from the dudh-walla and loose / kachi-ghani oil — which supply a huge share of Indian household consumption — carry no +F logo. Look for the +F symbol on every milk and oil pack you buy.
For Jain and strict-vegetarian families where dietary D3 is functionally zero, this is the case where lichen-derived vegan D3 supplementation matters. Lichen-derived D3 is biochemically identical to lanolin-derived D3 (the standard form, extracted from sheep wool), with equal potency and bioavailability. D2 (ergocalciferol) — the older “vegetarian” option — is roughly one-third as potent and has a shorter half-life. If you eat well and care about protein-rich Indian foods with bioavailability data, vitamin D is the one nutrient where vegetarian Indian diets cleanly lose to non-vegetarian ones.
Who actually needs the vitamin D test in 2026?
The hard answer per the 2024 Endocrine Society guideline is: most healthy Indian adults do not need the test. Order it only when there is a real indication. The list below is the operational version of the guideline plus ISBMR / IAP / FOGSI Indian practice.
Indications to test:
- Suspected osteomalacia — bone pain, low-back pain, proximal myopathy (difficulty rising from a low chair, climbing stairs), waddling gait, fragility fracture
- Suspected nutritional rickets in children — bow legs, delayed milestones, craniotabes, frontal bossing, widened wrists
- Pregnancy with risk factors — full-body covering, prior poor outcome, history of deficiency
- Malabsorption — celiac disease, IBD (Crohn’s, UC), post-bariatric surgery, chronic pancreatitis, cystic fibrosis
- Chronic kidney disease — stage 3 and above (CKD-MBD workup)
- Chronic liver disease — cirrhosis, severe hepatitis
- Long-term medications — antiepileptics (phenytoin, carbamazepine, phenobarbitone), glucocorticoids, antiretrovirals, antifungals, rifampin
- Elderly with falls or fracture — especially institutional / housebound
- Suspected granulomatous disease — sarcoidosis, TB (where 1,25(OH)2D testing may also be needed)
- Post-bariatric surgery follow-up
Indications NOT to test (per Endocrine Society 2024):
- Generic fatigue or “tiredness” workup
- Generalised body aches without proximal myopathy
- Hair fall workup (no good evidence link)
- Routine healthy-adult full-body checkup
- Pre-pregnancy planning in healthy women
- Dark-skinned or obese adults without specific symptoms
- Anxiety / depression workup as the primary investigation (consider the wider anxiety workup approach and the depression types and treatment guide instead — vitamin D is not a primary investigation for these)
What most people get wrong here: vitamin D is being used as a catch-all explanation for unexplained symptoms in Indian OPD practice. Fatigue, body aches, hair loss, brain fog, low mood, weight gain — all overlap perfectly with iron deficiency anaemia (the right test is the CBC normal range guide), hypothyroidism (the right tests are TSH/T4), B12 deficiency, depression, sleep deprivation, and post-viral syndromes. Pinning everything on a sub-30 ng/mL vitamin D level often misses the real diagnosis.
What is the standard vitamin D dosing protocol in India when treatment is genuinely indicated?
The Indian standard protocol for confirmed adult deficiency (<20 ng/mL) is cholecalciferol (vitamin D3) 60,000 IU orally once weekly for 6-8 weeks, then 60,000 IU once monthly maintenance — or 1,000-2,000 IU daily as maintenance. Paediatric and pregnancy doses differ. Doses are always cholecalciferol (D3), not ergocalciferol (D2), because D3 is ~3x more potent and longer-acting.
| Group | Loading dose | Maintenance | Source |
|---|---|---|---|
| Adult, deficient (<20 ng/mL) | 60,000 IU/week PO × 6-8 weeks | 60,000 IU/month OR 1,000-2,000 IU/day | ISBMR / IJEM 2025 |
| Adult, RDA (no deficiency) | None | 600 IU/day | ICMR-NIN 2020 RDA |
| Child <1 year (routine) | None | 400 IU/day | IAP 2021 |
| Child 1-18 years (routine) | None | 600 IU/day | IAP 2021 |
| Child, deficient (<12 ng/mL) | 2,000-3,000 IU/day × 12 weeks | Then RDA | IAP 2021 |
| Pregnancy (RDA) | None | 600 IU/day | ICMR-NIN / FOGSI |
| Pregnancy, deficient | 60,000 IU/week × 4-8 weeks | Then RDA | FOGSI common practice |
| Elderly, post-fracture | 60,000 IU/week × 8 weeks | 60,000 IU/month + calcium 1g/day | ISBMR |
Critical practical rules
- Take with a fatty meal. Cholecalciferol is fat-soluble. Absorption improves by ~32% with a meal containing ghee, paneer, eggs, or nuts versus an empty stomach.
- D3, not D2. Cholecalciferol (Calcirol, Uprise-D3, Deviron, Bio-D3 Strong, Tayo) over ergocalciferol — three times more potent.
- Magnesium matters. Magnesium is a cofactor for both 25-hydroxylase and 1-alpha-hydroxylase. If you supplement vitamin D and your level does not rise, check magnesium intake (leafy greens, almonds, sesame, whole grains) or supplement 200-400 mg/day.
- Calcium too. Vitamin D without adequate calcium (1,000-1,200 mg/day from diet + supplement) will mobilise calcium from bone, worsening bone loss. This is especially important in pregnancy and postmenopausal osteoporosis — see our companion piece on the iron-calcium-chai pregnancy absorption timing trap for why timing matters here too.
- One sachet per WEEK, not per day. Read the label.
Brand and price reference (India 2026)
| Brand | Manufacturer | Form | Approx MRP |
|---|---|---|---|
| Calcirol 60K sachet | Cadila Healthcare / Zydus | Granules, 1 g sachet | ₹35-₹45 |
| Uprise-D3 60K capsule | Alkem Laboratories | Softgel | ₹40-₹60 |
| Deviron 60K | Eris Lifesciences | Oral solution/granules | ₹40-₹70 |
| Bio-D3 Strong 60K | TTK Healthcare | Granules / softgel | ₹35-₹70 |
| Tayo 60K | Various | Sachet | ₹30-₹50 |
| Shelcal 500 + D3 250 IU | Torrent | Tablet (combo) | ₹140 / 15 tabs |
An 8-week loading course at one sachet a week costs ₹280-₹720 total. That is cheaper than a single vitamin D test at the premium end, which is itself part of why this entire test-treat-retest cycle keeps spinning.
How serious is vitamin D toxicity from Calcirol — and how to avoid it?
Vitamin D toxicity is rising in Indian case reports and is almost always iatrogenic — caused either by prescribing error or, more commonly, by patients taking the 60,000 IU sachet daily instead of weekly because the box does not say “once per week” clearly enough.
| Toxicity scenario | Total dose | Typical 25(OH)D level | Clinical effect |
|---|---|---|---|
| 60K daily x 2 months (most common Indian error) | 3.6 million IU | >150 ng/mL | Hypercalcaemia, AKI, sometimes heart block |
| Single IM injection 6L IU (private GP “boost”) | 600,000 IU | 80-120 ng/mL transiently | Usually OK but no benefit over oral |
| Chronic >10,000 IU/day | Variable | >100 ng/mL | Symptomatic toxicity over weeks |
| Self-medication from chemist | Variable | Variable | Most common cause of Indian case reports |
The Kashmir Valley tertiary-care prospective study on vitamin D toxicity documented 10 cases with intake ranging 50,000 to 2,604,000 IU/day. Indian Journal of Pain 2024 published a “Hypervitaminosis D Due to Overdose” case series. Indian Journal of Endocrinology reports include heart-block cases from over-prescribed weekly sachets taken daily.
Hypercalcaemia symptoms to know
The classical mnemonic — stones, bones, abdominal groans, psychic moans — translates clinically to:
- Anorexia, nausea, vomiting
- Polyuria, polydipsia, dehydration
- Constipation
- Confusion, lethargy, depression, headache
- Kidney stones, nephrocalcinosis, AKI
- Rarely: complete heart block, pancreatitis
If you or a family member has been taking 60,000 IU sachets daily and develop any of the above, stop the supplement immediately and see a physician for serum calcium, creatinine, and 25(OH)D.
Tolerable Upper Intake Level (UL): IOM sets 4,000 IU/day for adults; Endocrine Society allows up to 10,000 IU/day in adults under supervised repletion. Long-term healthy-adult intake above 4,000 IU/day without indication is not justified.
What does the recent research actually say about vitamin D and disease prevention?
The marketing claims around vitamin D for cancer, cardiovascular disease, fracture, depression, immunity, and COVID-19 are not supported by the highest-quality RCT evidence. The three trials that matter most all failed their primary endpoints.
| Trial | Year, N | Dose | Primary endpoint result |
|---|---|---|---|
| VITAL (NEJM) | 2018, 25,871 US adults | 2,000 IU/day × 5.3 y | NO reduction in invasive cancer or major CV events |
| VITAL-Fractures (NEJM) | 2022, 25,871 | 2,000 IU/day × 5.3 y | NO reduction in total, hip, or non-vertebral fractures |
| D2d (NEJM) | 2019, 2,423 prediabetics | 4,000 IU/day | HR 0.88 (95% CI 0.75-1.04) for diabetes — NOT statistically significant |
| Mendelian randomisation (multiple) | 2019-2023 | Genetic IV | NO causal effect on most chronic disease in replete adults |
| Cochrane / Lancet D&E 2024 ARI meta-analysis | 2024 | Various | Small ~8% reduction in acute respiratory infection; 2024 trials in elderly null |
The conclusion most reasonable researchers now reach: treat the genuinely deficient (especially infants, pregnant women, elderly with osteomalacia, post-bariatric, chronic medication users) and stop chasing universal supplementation in healthy adults. The signal for benefit shrinks rapidly the more replete the population already is. Indian-specific data — where some genuine sub-populations have very low intake — still supports targeted supplementation in vegetarian/Jain populations, infants, and pregnant women — but not blanket OPD-wide prescription.
The companion piece on the NIH Office of Dietary Supplements vitamin D fact sheet summarises the evidence base in clinical terms; it is the cleanest non-promotional reference for Indian clinicians.
How should you build a smart, low-cost annual lab panel that includes vitamin D?
If you fall into the high-risk groups above, the test belongs in your annual panel — but bundled, not standalone. A sensible annual approach for an Indian adult with a real indication:
- Time it once a year, ideally end of winter (February-March). Vitamin D nadirs in late winter; testing then captures the worst case.
- Bundle with B12 and a thyroid panel. All three are commonly deficient in vegetarian/Jain Indians, all share symptoms, and bundling drops the marginal cost.
- Combine with a routine CBC, HbA1c, and lipid profile (the HbA1c diabetes screening guide and the lipid profile India guide cover those tests in depth) to use the chain’s package pricing.
- Use Redcliffe / Thyrocare / Tata 1mg for standard CLIA testing. Reserve Metropolis or SRL LC-MS/MS for genuine high-precision needs (sarcoidosis, post-bariatric, malabsorption workup).
- Always skip the morning supplement on test day to avoid spuriously high readings.
- No fasting needed — book any time slot.
What most people get wrong here: paying ₹1,800 for a standalone vitamin D test when the same panel inside a ₹1,999 “Full Body Checkup” bundle gives you CBC + lipids + HbA1c + B12 + thyroid + vitamin D at one-third the marginal cost. Bundled is always cheaper. Ask the lab for the bundle price before booking a standalone.
Medical Disclaimer
This article is for general health information and is not a substitute for personalised medical advice from a qualified physician. Vitamin D testing and supplementation decisions should be made on a clinical basis with your treating doctor, taking into account your full history, medications, and risk factors. Reference ranges, doses, and brand prices are based on Indian Council of Medical Research, Indian Academy of Pediatrics, Endocrine Society 2024, ISBMR, and major Indian diagnostic chains as of 2026 and may change. If you have symptoms of hypercalcaemia (severe nausea, confusion, polyuria, kidney pain) while on vitamin D supplements, stop the supplement and seek medical care. Cost ranges are India 2026 estimates and vary by city, lab, and bundling.
Sources & References
- 2024 Endocrine Society Guideline: Vitamin D for the Prevention of Disease — Clinical Practice Guideline
- ICMR-NIN: ICMR-NIN 2020 Recommended Dietary Allowances (Vitamin D — 600 IU/day adults)
- IAP 2021 paediatric vitamin D guideline: Indian Academy of Pediatrics — Prevention and Treatment of Vitamin D Deficiency
- IJEM 2025 Indian Expert Consensus: Indian Journal of Endocrinology and Metabolism — Prevention and Treatment of Vitamin D Deficiency in India
- Nutrients 2014 review of Indian vitamin D status: Vitamin D Deficiency in India: Prevalence, Causalities and Interventions
- VITAL trial: NEJM 2018 — Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
- VITAL-Fractures: NEJM 2022 — Supplemental Vitamin D and Incident Fractures
- D2d trial: NEJM 2019 — Vitamin D Supplementation and Prevention of Type 2 Diabetes
- NIH ODS Fact Sheet: NIH Office of Dietary Supplements — Vitamin D Health Professional Fact Sheet
- FSSAI fortification standards: Food Safety and Standards Authority of India — Fortification +F logo regulations
- Vitamin D toxicity Indian case series: Vitamin D Toxicity: A Prospective Study from Tertiary Care Centre Kashmir Valley
- Indian threshold debate: Estimating Vitamin D Threshold for the Indian Population — Delving into Actual Disease Burden
Stop testing vitamin D reflexively. Start by asking whether you have a real indication — and if not, take the 600 IU/day RDA, fix your loose-milk and oil to FSSAI +F brands, eat a fatty fish or egg yolk when you can, sit in the midday sun for 15-30 minutes three times a week with your face and arms uncovered, and check vegan D3 if you are Jain or vegetarian. If you do have an indication, the Redcliffe ₹499 or Thyrocare ₹600-₹900 standalone tests are accurate enough, the 60,000 IU weekly cholecalciferol protocol is well-established, and the toxicity risk is real only when you do not read the label. The 2024 Endocrine Society guideline is the most important thing your doctor probably has not yet updated to. Print it. Bring it.